As the patent for semaglutide nears its end, Novo Nordisk's dominance in the weight-loss market is being challenged. The ...

Recently, tennis legend Serena Williams opened up about using weight-loss medication, aiming to break the ‘stigma’ around ...

My name is Louise, and I am addicted to Mounjaro. I feel amazing - super healthy, energised, and happier in my skin than I ...

Prescriptions for popular weight-loss drug Wegovy have soared in Korea, reaching nearly 400,000 just eight months after its launch. But doctors and health officials warn of reckless use far beyond the ...

Eli Lilly and Company (NYSE: LLY) is one of the best stocks to invest in for long-term growth. Eli Lilly and Company ...

Given the potential side effects of GLP-1 prescription drugs, many Utahns are seeking alternative methods to naturally boost ...

Eli Lilly's orforglipron could have a few advantages over a pill from Novo Nordisk, including a lack of dietary restrictions ...

The weight-loss drug Wegovy just got FDA approval to treat a common and serious liver condition known as MASH (Metabolic ...

COMMENT: The monthly cost of a private prescription exceeding £300 from next month is worrying news for the half a million ...

A Comeback Fueled by Resilience Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) has been a trailblazer in the GLP-1 drug ...

With results from highly anticipated trials of Eli Lilly’s orforglipron and Viking Therapeutics’ VK2735 “underwhelming” ...

The retired tennis pro explained that she’s trying to combat the stigma associated with weight loss drugs after losing 31 ...